Skip to content

Advertisement

  • Research article
  • Open Access

Increase in the astaxanthin synthase gene (crtS) dose by in vivo DNA fragment assembly in Xanthophyllomyces dendrorhous

  • 1,
  • 1,
  • 2,
  • 1,
  • 1 and
  • 1Email author
BMC Biotechnology201313:84

https://doi.org/10.1186/1472-6750-13-84

  • Received: 12 July 2013
  • Accepted: 4 October 2013
  • Published:

Abstract

Background

Xanthophyllomyces dendrorhous is a basidiomycetous yeast that is relevant to biotechnology, as it can synthesize the carotenoid astaxanthin. However, the astaxanthin levels produced by wild-type strains are low. Although different approaches for promoting increased astaxanthin production have been attempted, no commercially competitive results have been obtained thus far. A promising alternative to facilitate the production of carotenoids in this yeast involves the use of genetic modification. However, a major limitation is the few available molecular tools to manipulate X. dendrorhous.

Results

In this work, the DNA assembler methodology that was previously described in Saccharomyces cerevisiae was successfully applied to assemble DNA fragments in vivo and integrate these fragments into the genome of X. dendrorhous by homologous recombination in only one transformation event. Using this method, the gene encoding astaxanthin synthase (crtS) was overexpressed in X. dendrorhous and a higher level of astaxanthin was produced.

Conclusions

This methodology could be used to easily and rapidly overexpress individual genes or combinations of genes simultaneously in X. dendrorhous, eliminating numerous steps involved in conventional cloning methods.

Keywords

  • Xanthophyllomyces dendrorhous
  • Astaxanthin synthase
  • DNA assembler

Background

Xanthophyllomyces dendrorhous is a basidiomycetous yeast with potential in the biotechnology industry as it is able to synthesize carotenoids, particularly astaxanthin. Carotenoids are natural yellow, orange, or red pigments, and more than 700 different carotenoid chemical structures have been described to date [1]. Animals are unable to synthesize these pigments de novo and can only obtain them in their diet. These pigments are currently used as food colorants and have received attention for their ability to alleviate chronic diseases due to their antioxidant properties, which can mitigate the damaging effects of oxidative stress induced by reactive oxygen species (ROS) [2]. Among carotenoids, astaxanthin (3,3′-dihydroxy-β,β-carotene-4-4′-dione) is notable based on its antioxidant properties, which are greater than those of beta-carotene or even alpha-tocopherol [3], and the application of astaxanthin in the pharmaceutical and cosmetic industries has recently been explored [4]. Astaxanthin has also been widely used in the aquaculture industry as a colorant for cultured salmonids to achieve the flesh color that is preferred by consumers. In addition, astaxanthin is an essential nutritional component for proper fish growth and reproduction, making this compound a significant factor in aquaculture production costs [4].

X. dendrorhous is one of the few microorganisms that produces astaxanthin. However, the production of this pigment by wild-type strains is too low (200–400 μg per g of dry yeast) to provide a natural source that is economically competitive with chemical synthesis of this pigment. Therefore, many efforts have attempted to improve the astaxanthin production from X. dendrorhous, including optimization of culture conditions such as glucose concentration [5, 6], oxygen levels [6, 7], pH [8, 9], carbon/nitrogen ratio [10], and light intensities [11], in addition to classic random mutagenesis methods [1215]. A promising alternative to increase the astaxanthin yield in this yeast is to overexpress the genes involved in carotenoid synthesis (Figure 1) for which several attempts have been performed (For a review see: [16]). A small increase in the amount of total carotenoids was obtained by overexpressing the gene encoding phytoene synthase-lycopene cyclase (crtYB) by integrating multiple copies of this gene into the ribosomal DNA [17]. However, this increase was mainly due to increased synthesis of beta-carotene and echinenone, while the astaxanthin content was slightly reduced (or unaffected). In another experiment in which the gene encoding phytoene desaturase (crtI) was overexpressed, the overall carotenoid production decreased including a 50% reduction in the astaxanthin fraction [17]. Similarly, the overexpression of the gene encoding isopentenyl pyrophosphate isomerase (idi) led to a decrease in the amount of total carotenoids [18]. In another work attempting to promote metabolite flow towards carotenoid biosynthesis, the cDNA encoding the geranylgeranyl pyrophosphate synthase gene (crtE) was overexpressed, resulting in a strain with slightly higher carotenoid levels, although the astaxanthin levels were not increased [19]. However, the simultaneous insertion of extra copies of the crtYB and crtS (which encodes the astaxanthin synthase) genes in an astaxanthin-overproducing strain obtained by random mutagenesis resulted in transformants with an even higher astaxanthin content [20]. Therefore, the overexpression of a single gene is not enough to significantly increase the astaxanthin level in X. dendrorhous, and overexpression of different combinations of carotenogenic genes seemed to provide better results.
Figure 1
Figure 1

Diagram of the astaxanthin biosynthetic pathway in X. dendrorhous . The astaxanthin biosynthesis pathway in X. dendrorhous proposed by [21] and [22]. Metabolite abbreviations: IPP (isopentenyl pyrophosphate), DMAPP (dimethylallyl pyrophosphate), GPP (geranyl pyrophosphate), FPP (farnesyl pyrophosphate), GGPP (geranylgeranyl pyrophosphate) and HDCO (3-hydroxy-3′,4′-didehydro-β,ψ-carotene-4-one). The names of the genes controlling each step are written in red: idi (IPP-isomerase), crtE (geranylgeranyl pyrophosphate synthase), crtYB (PBS, phytoene-β-carotene synthase), crtI (PDS, phytoene desaturase), crtS (astaxanthin synthase) and crtR (cytochrome P450 reductase).

One of the major limitations in the genetic manipulation of X. dendrorhous is the limited number of molecular tools available to transform and engineer this yeast. Recently, an in vivo method for DNA fragment assembly and yeast transformation, DNA assembler, was reported [23]. With this technique, numerous DNA fragments are assembled in vivo via homologous recombination at their ends following a single transformation event, allowing the incorporation of an entire heterologous biochemical pathway in Saccharomyces cerevisiae. As the X. dendrorhous homologous recombination machinery has previously been successfully exploited for the development of transformation strategies and gene function analysis [17, 2427], in this work, we adapted the DNA assembler methodology to overexpress the gene encoding astaxanthin synthase (crtS) that catalyzes the formation of astaxanthin from beta-carotene [28, 29] in X. dendrorhous.

Results

In vivo assembly and integration of DNA fragments into the genome of X. dendrorhous

To evaluate the feasibility of assembling DNA fragments in vivo in X. dendrorhous, a DNA cassette containing only the gene that confers resistance to hygromycin B [30] was integrated in the genome of the wild-type X. dendrorhous strain UCD 67–385. A 1,260 bp locus called DHS3 [GenBank: JN835289.1] was chosen as one of the potential target site, which is located at 2,110 bp downstream of the X. dendrorhous HIS3 gene. This region is transcribed and encodes an uncharacterized gene product, so we expected that its interruption would not drastically affect the physiology of the yeast.

Three DNA fragments (454 bp DHS3 “up” for upstream, 1,817 bp hygromycin B resistance cassette and 460 bp DHS3 “down” for downstream) were prepared as illustrated in Figure 2A. First, each fragment was individually PCR amplified with a set of primers designed to make the 5′ end of the fragment overlap the 3′ end of the preceding DNA fragment. In this way, the hygromycin B resistance cassette overlaps the two flanking DNA fragments targeting the DHS3 locus. The overlapping region contained approximately 100 bp of sequence homology between fragments to allow in vivo homologous recombination between them. A diploid X. dendrorhous wild-type strain [31] was co-transformed with the three DNA fragments by electroporation. Assembly of these fragments and their integration into the genome was accomplished, as nine hygromycin B-resistant transformants were obtained. PCR analyses confirmed that all of them contained the resistance cassette at the expected integration target. However, as the starting strain UCD 67–385 is diploid [31], a wild-type DHS3 allele was still detected in the resulting transformants, indicating that they were heterozygous at this locus. For this reason, one of the transformants was randomly chosen (named Xd_1H, for one hygromycin-resistance cassette copy) to obtain the homozygous strain Xd_2H (2H for two copies of the hygromycin-resistance cassette) using the double recombinant method (DRM) [30] (Figure 2A). Panel B of Figure 2 shows the amplicons obtained from genomic PCR confirming the integration of the hygromycin B resistance cassette into the expected locus in strains Xd_1H (DHS3/dhs3::hph) and Xd_2H (dhs3::hph/dhs3::hph). To the naked eye, the color of the heterozygous and homozygous strains is identical to the wild-type strain and both strains are able to grow in minimal medium (Figure 2C). Total carotenoids were quantified and no significant differences were detected between the transformants and the wild-type strain (data not shown). Thus, the interruption of the DHS3 locus did not cause auxotrophy or greatly affected the carotenogenesis in this yeast.
Figure 2
Figure 2

Assembly and integration of the hygromycin B resistance cassette into the genome of X. dendrorhous by DNA assembler. A) Three DNA fragments, DHS3 “up”, hph expression cassette (composed by EF-1α promoter, hph gene and gpd terminator) and DHS3 “down” were amplified by PCR to direct the integration of the hygromycin B cassette into the DHS3 locus of the X. dendrorhous genome. Then, they were co-transformed, assembled (by recombination at their overlapping ends) and integrated into the X. dendrorhous genome. The arrows represent the primers used and the black crosses represent the in vivo homologous recombination event. By this way, the heterozygous strain was obtained, which was submitted to the double recombinant method (DRM) to obtain the homozygous strain. B) Evaluation of the hygromycin B cassette integration by PCR of strains Xd_1H (1H, one hygromycin B cassette copy), Xd_2H (2H, two hygromycin B cassette copies) and parental UCD 67–385 (WT), and control without DNA (-). A scheme representing the primer sets (in arrows and numbers according to Additional file 1: Table S1) that were used and the DNA target are included under each gel photograph. M: Molecular marker, lambda DNA digested with HindIII. C) Color phenotype of strains Xd_1H (1H), Xd_2H (2H) and parental UCD 67–385 (WT) grown on an MMV agar plate.

To confirm that this transformation methodology is effective for other integration targets, the resistance cassette was successfully integrated into two other genomic loci. However, the color phenotype of the transformants was different from the parental strain (data not shown).

Increase of crtSgene dose

Next, we used the above methodology to increase the crtS gene dose. A crtS expression cassette was constructed by OE-PCR (overlap extension- PCR) and cloned into plasmid pBluescript SK-, resulting in the plasmid pBS-PTEF-crtS-Tact. This cassette was integrated in the DHS3 locus, as its interruption did not cause auxotrophy or greatly affected the carotenogenesis in this yeast. Four DNA fragments (the hygromycin B-resistance selection marker, the crtS gene expression cassettes, and the DHS3 locus “up” and “down” targeting fragments) were individually PCR amplified with primers allowing 50 to 100 bp of overlap between adjacent fragments, and then these fragments were used to co-transform X. dendrorhous by electroporation (Figure 3). Four hygromycin B-resistant colonies were obtained. All had the crtS gene expression cassettes at the expected locus, as confirmed by PCR analyses with a comprehensive set of primers. One of these four colonies was randomly selected, named strain Xd_1H1S (DHS3/dhs3::hph+crtS, one additional crtS gene copy) and subjected to DRM to result in a homozygous strain, Xd_2H2S (dhs3::hph+crtS/dhs3::hph+crtS). The PCR amplification confirmed the insertion of the hygromycin B resistance and crtS expression cassettes at the DHS3 locus in the heterozygous and homozygous transformants are shown in Figure 4.
Figure 3
Figure 3

Assembly and integration of hygromycin B resistance and crtS gene expression cassettes into the DHS3 locus of X. dendrorhous by DNA assembler. Four DNA fragments: DHS3 “up”, hph expression cassette (composed by EF-1α promoter, hph gene and gpd terminator), crtS gene expression cassette (composed by EF-1α promoter, crtS gene and actin transcription terminator) and DHS3 “down” were amplified by PCR to direct the integration of exogenous genes into the DHS3 locus of the X. dendrorhous genome. Arrows represent the primers used (Additional file 1: Table S1).

Figure 4
Figure 4

PCR-based analysis of the crtS expression cassette and hygromycin B resistance cassette integration into the genome of X. dendrorhous . PCR analyses of Xd_1H1S (1S, one additional crtS gene copy), Xd_2H2S (2S, two additional crtS gene copies), and parental UCD 67–385 (WT) strains, and the negative control without DNA (-). A scheme representing the primers sets that were used (in arrows and numbers according to Additional file 1: Table S1) and the DNA target are under each gel photograph. The scheme shading is in accordance with Figure 3. M: Molecular marker, lambda DNA digested with HindIII.

To assess whether the increase in the crtS gene dose effectively leads to an increase in the crtS mRNA levels, RT-qPCR analysis was performed for the wild-type, heterozygous and homozygous transformants grown under the same conditions. Total RNA was extracted after 50 h of culture (late exponential phase of growth) of each strain as it was observed that the crtS mRNA level reaches its maximum level at this stage [32, 33]. The relative crtS expression was normalized to the expression of the actin gene [34], and RT-qPCR analysis revealed that the expression of the crtS gene was increased approximately three fold in the Xd_2H2S strain with respect to the wild-type strain (UCD-67-385) at this same growth stage (Figure 5).
Figure 5
Figure 5

RT-qPCR expression analysis of crtS in the wild-type strain and crtS- overexpressing transformants. The crtS transcript level was normalized to the actin mRNA and was determined from RNA extracted after 50 h of culture in YM medium from the parental wild-type UCD 67–385 (WT), the heterozygous Xd_1H1S (DHS3/dhs3::hph+crtS) and homozygous Xd_2H2S (dhs3::hph+crtS/dhs3::hph+crtS) strains. Values are the mean ± standard error of at least three independent cultures. (*P ≤ 0.05; Student’s t test).

Carotenoid production

To the naked eye, different pigmentation phenotypes among the wild-type, Xd_1H1S and Xd_2H2S strains could be noted. To confirm this observation, the carotenoid content and composition of these strains were analyzed. Total carotenoids were extracted from cell pellets from 24, 50 and 96-h-old yeast cultures (early exponential, late exponential and late stationary phase of growth, respectively) grown at 22°C in YM (yeast malt broth) medium with constant agitation. Carotenoids were extracted, quantified by absorbance at 465 nm and their composition was analyzed by RP-HPLC. The results are summarized in Table 1. Although the total carotenoid production is not affected in strains that overexpress crtS, it can be observed that after 50 and 95 h of culture, the percentage of astaxanthin in relation to the other carotenoids is higher in strains expressing additional crtS gene copies.
Table 1

Carotenoids in wild-type and transformant strains in ppm (μg per g of dry yeast)

 

X. dendrorhousstrain [ppm (%)]

 

UCD 67–385

Xd_1H1S

Xd_2H2S

( DHS3/ DHS3)

( DHS3/dhs3:: hph+crtS)

(dhs3:: hph+crtS/dhs3:: hph+crtS)

Cultivation time (h)

25

50

96

25

50

96

25

50

96

Carotenoid:

         

Total carotenoids

22.70±11.16

34.31±15.87

189.32±86.51

14.35±11.71

64.21±1.13

188.37±6.05

12.98±4.93

84.79±28.83

197.85±34.65

 

(100)

(100)

(100)

(100)

(100)

(100)

(100)

(100)

(100)

Beta-carotene

ND

4.37 ± 1.25

6.90 ± 0.57

ND

7.4 ± 0.01

3.93 ± 0.08

ND

2.36 ± 0.29

0.72 ± 0.22

(13)

(4)

(12)

(2)

(3)

(1)

Equinenone

ND

1.36 ± 0.31

7.01 ± 0.46

ND

2.84 ± 0.01

3.84 ± 0.05

ND

0.54 ± 0.32

0.88 ± 0.03

(4)

(4)

(4)

(2)

(1)

(1)

OH-equinenone

ND

4.65 ± 0.38

11.47 ± 1.10

ND

5.79 ± 0.01

7.29 ± 0.04

ND

8.85 ± 0.31

1.06 ± 0.16

(14)

(6)

(9)

(4)

(10)

(1)

Cantaxanthin

ND

0. 46 ± 0.12

2.24 ± 0.90

ND

0.73 ± 0

1.41 ± 0.05

ND

0.39 ± 0.12

0.83 ± 0.21

(1)

(1)

(1)

(1)

(1)

(1)

Phoenicoxanthin

0.46 ± 0.39

3.99 ± 0.37

28.41 ± 3.53

0.5 ± 0.41

6.65 ± 0.01

15.93 ± 0.01

ND

5.50 ± 0.41

11.08 ± 0.07

(2)

(12)

(15)

(3)

(10)

(8)

(6)

(6)

Astaxanthin

21.97 ± 0.62

18.81 ± 1.77

128.04 ± 5.06

13.85 ± 0.41

38.05 ± 0.04

154.13 ± 0.09

12.98 ± 0

65.84 ± 0.81

179.21 ± 0.52

(97)

(55)

(68)

(97)

(59)

(82)

(100)

(78)

(96)

Lycopene

ND

ND

ND

ND

ND

ND

ND

ND

0.51 ± 0.15

(1)

Neurosporene

ND

0.10 ± 0.04

ND

ND

0.54 ± 0.01

ND

ND

ND

ND

(0)

(1)

Torulene*

ND

0.07 ± 0.04

ND

ND

0.206 ± 0.01

ND

ND

ND

0.45 ± 0.03

(0)

(1)

(1)

OH-keto-torulene†*

ND

0.47 ± 0.20

0.76 ± 0.52

ND

1.72 ± 0.02

1.85 ± 0.02

ND

0.95 ± 0.24

1.49 ± 0.26

(1)

(1)

(2)

(1)

(1)

(1)

ND: Not detected. Table values correspond to the average result from three independent cultures ± standard deviations. Percentage relative to total carotenoids is indicated in parentheses. : hydroxy or/and keto carotenoid, *: monocyclic carotenoid.

Discussion

There are a limited number of currently available molecular tools to manipulate and transform X. dendrorhous. Until this report, transformation of X. dendrorhous usually required the construction of a plasmid for transformation [17, 2527], which involves several conventional steps of sequential cloning such as DNA amplification, endonuclease digestion, in vitro ligation and transformation. If the number of expression cassettes to incorporate in a host is increased, these processes will be time consuming and will depend on the availability of restriction sites in the cloning vector. In contrast, the DNA assembler method requires only DNA fragments with homologous ends. We find that this methodology works in X. dendrorhous as we transformed this yeast with three DNA fragments to integrate a hygromycin B resistance cassette into its genome. We also increased the number of crtS gene copies in this yeast by transforming it with four DNA fragments to be assembled (5,098 kb in total) and integrated in the yeast genome. We conclude that this methodology can be employed to engineer X. dendrorhous to interrupt or increase gene copy number of several combinations of genes in only one transformation event.

In previous studies attempting to overexpress genes in X. dendrorhous, expression cassettes were integrated into ribosomal DNA (rDNA) [1720]. There are approximately 60 rDNA copies in X. dendrorhous[24], which favors multiple integrations of the transformant DNA into the genome. However, due to the tandem repeats in this region, the resulting strains are typically unstable as the integrated genes may be lost by homologous recombination. Additionally, the use of this region makes it difficult to evaluate the effect of gene dose on the production of carotenoids, as it is difficult to quantify the number of integrated cassette copies. For these reasons, we excluded the rDNA region as a target site for integration and focused on integration and resultant target site disruption in a locus that does not strongly modify the yeast physiology. From the analyzed targets, the disruption of locus DHS3 fulfilled this requirement, so it was chosen to integrate the additional crtS gene copies.

In this work, we studied the effect of altering the metabolic flux between beta-carotene and astaxanthin by increasing the crtS gene dose. Although the total carotenoid content in strains with one or two additional crtS gene copies was not substantially modified (Table 1), an increased proportion of astaxanthin relative to the total carotenoid content was obtained in the strain with two additional crtS gene copies compared to the wild-type strain. Astaxanthin represented 96% versus 68% of the carotenoids in these strains after 96 h of culture. In addition, reduced proportions of beta-carotene and intermediate xanthophylls formed during the synthesis of astaxanthin from beta-carotene such as echinenone, hydroxyechinenone, canthaxanthin and phoenicoxanthin. These observations suggest that astaxanthin synthesis is limited by the amount of astaxanthin synthase substrate, beta-carotene. Thus, to achieve a significantly higher level of astaxanthin production, it is also necessary to increase the synthesis of beta-carotene. In agreement with this assumption, it has been observed that the overexpression of the crtYB gene in X. dendrorhous resulted in increased beta-carotene production [17] and recently, the simultaneous overexpression of the crtYB and crtS genes in a X. dendrorhous strain created via random mutagenesis that already overproduced astaxanthin resulted in a higher astaxanthin content compared to the parental strain (5,300 ppm) [20]. The methodology described in this work should be a helpful tool to evaluate the consequences of overexpressing different combinations of genes involved in carotenoid production in X. dendrorhous.

Although beta-carotene was almost completely exhausted in the transformant strain that overexpressed crtS, phoenicoxanthin, the xanthophyll precursor to astaxanthin, was still present, although its proportion was reduced from 15% to 6% after 96 h of culture in the wild-type and in the Xd_2H2S strains, respectively. As astaxanthin synthase is a cytochrome P450 enzyme, it may also be necessary to increase the cytochrome P450 reductase [25] gene dose to enhance the activity of this enzyme.

The DNA assembler methodology that has been effective and successful in X. dendrorhous in this study should be useful to overexpress several genes simultaneously to favor the synthesis of carotenoid precursors such as geranylgeranyl pyrophosphate or genes involved in the mevalonate pathway [35] in combination with carotenogenic genes. Thus, using different promoters in the construction of the gene expression cassettes, it should be possible to increase and modulate the production of carotenoids in X. dendrorhous.

Conclusions

The DNA assembler method is a successful technique to transform X. dendrorhous. This technique allowed an increase in the crtS gene copy number in the X. dendrorhous genome. The overexpression of this gene did not significantly change the total carotenoid production, but there was an increase in the astaxanthin fraction of carotenoids.

As DNA assembler requires only DNA fragments with homologous ends, this technique could be useful to quickly and easily overexpress several genes simultaneously in X. dendrorhous, saving numerous steps involved in conventional cloning methods.

Methods

The experiments performed in this work were approved by the Facultad de Ciencias – Universidad de Chile, Ethics Committee.

Microorganisms, plasmids, media, and enzymes

The strains and plasmids that were used and built in this work are listed in Table 2. The wild type X. dendrorhous strain UCD 67–385 (ATCC 24230) was used as a parental strain for transformation experiments and E. coli DH-5α was used as a host for plasmid propagation.
Table 2

Strains and plasmids used and built in this work

 

Genotype or relevant features

Source or reference

Strains:

  

E. coli:

  

DH-5α

F- φ80d lacZΔM15Δ (lacZY-argF) U169 deoR recA1 endA1 hsdR17(rk- mk+) phoA supE44l- thi-1 gyrA96 relA1

[37]

X. dendrorhous:

  

UCD 67-385

ATCC 24230, wild-type. Diploid strain [31].

ATCC

Xd_1H

(DHS3/dhs3::hph). Heterozygote transformant derived from UCD 67–385 containing an allele of the DHS3 locus with a deletion and a hygromycin B resistance cassette.

This work

Xd_2H

(dhs3::hph/dhs3::hph). Homozygote transformant derived from Xd_1H by DRM [30] with a deletion and a hygromycin B resistance cassette in both alleles of the DHS3 locus.

This work

Xd_1H1S

(DHS3/dhs3::hph+crtS). Heterozygote transformant derived from UCD 67–385 with a deletion in one DHS3 allele and bearing the hygromycin B resistance cassette and the crtS gene expression cassette.

This work

Xd_2H2S

(dhs3::hph+crtS/dhs3::hph+crtS). Homozygote transformant derived from Xd_1H1S by DRM with a deletion in both DHS3 alleles and bearing the hygromycin B resistance cassette and the crtS gene expression cassette.

This work

Plasmids:

  

pBluescript SK- (pBS)

ColE1 ori; AmpR; cloning vector for blue-white selection

Stratagene

pMN-hph

pBS containing a cassette of 1.8 kb bearing the resistance Hygromycin B (hph) gene under EF-1 α promoter and gpd transcription terminator of X. dendrorhous in its EcoRV site.

[30]

pXd_Ex_crtS

pBS containing the cDNA encoding the X. dendrorhous crtS gene in its EcoRV site.

[26]

pBS-PTEF-crtS-Tact

pBS containing a 2,367 bp cassette bearing the cDNA encoding the X. dendrorhous crtS gene under EF-1α promoter and the actin transcription terminator from X. dendrorhous in the EcoRV site.

This work

ATCC: American Type Culture Collection.

DHS3 [GenBank: JN849376.1]: locus downstream of the X. dendrorhous HIS3 gene [GenBank: JN849374.1].

X. dendrorhous strains were grown at 22°C with constant agitation in YM medium (1% glucose, 0.3% yeast extract, 0.3% malt extract and 0.5% peptone) or minimal MMV + 2% glucose medium [36]. Yeast transformant selection was performed on YM 1.5% agar plates supplemented with 15 μg/ml hygromycin B. E. coli strains were grown with constant agitation at 37°C in Luria-Bertani (LB) medium and supplemented with 100 μg/ml ampicillin for plasmid selection and 80 μg/ml X-gal (5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside) for recombinant clone selection [37].

Enzymes were purchased from Promega (Taq DNA pol, restriction enzymes, M-MLV reverse transcriptase) and Pfu DNA pol was purchased from Agilent Technologies.

DNA amplification

All of the nucleotides used in this work were purchased from Alpha DNA (Montreal, Canada) or from Integrated DNA Technologies and are listed in Additional file 1: Table S1. PCR reactions were performed in a final volume of 25 μl containing 2 U of Taq DNA pol, 2.5 μl of 10× Taq buffer, 0.5 μl of 10 mM dNTPs, 1 μl of 50 mM MgCl2, 1 μl of 25 μM of each primer and 10–20 ng of template DNA. Amplification was performed in a DNA thermal cycler 2720 (Applied Biosystems) as follows: initial denaturation at 95°C for 3 min; 35 cycles of denaturation at 94°C for 30 s, annealing at 55°C for 30 s, synthesis at 72°C for 3 min and a final extension step at 72°C for 10 min. Samples were kept at 4°C until use. The amplicons were separated by 0.8% agarose gel electrophoresis in TAE buffer containing 0.5 μg/ml ethidium bromide [37] followed by DNA purification using the Glassmilk method [38] for sequencing or gene expression cassette construction.

To reduce the error rate in DNA amplification for Overlap Extension-PCR (OE-PCR, [39] and DNA fragment amplification for X. dendrorhous transformation, Pfu DNA pol was used instead of Taq DNA pol following the manufacturer’s instructions.

Cloning and construction of the crtSgene expression cassette

The crtS gene expression cassette was constructed by Overlap Extension-PCR (OE-PCR) [39] containing 1,674 bp of the cDNA of the crtS gene [GenBank: DQ002007.1] under the control of 393 bp of the X. dendrorhous EF-1α promoter [26] and 300 bp of the actin transcription terminator of [GenBank: X89898.1]. The EF-1α promoter region was amplified by PCR with primers 1 and 2 (Additional file 1: Table S1) using pMN-hph as a template (Table 2), and the actin gene terminator was amplified from UCD 67–385 genomic DNA using primers 5 and 6 (Additional file 1: Table S1). The crtS cDNA was amplified from pXd_Ex_crtS (Table 2) with primers 3 and 4 (Additional file 1: Table S1). First, the promoter region was joined to the crtS cDNA and then the hybrid product was joined to the actin gene transcription terminator by OE-PCR. The resulting cassette was cloned into the EcoRV site of plasmid pBS (pBS-PTEF-crtS-Tact, Table 2) and was sequenced on both strands using a DYEnamic ET Terminator Kit (Amersham Bioscience) in an ABI 3100 Avant genetic analyzer. DNA sequences were analyzed with Vector NTI Suite 10 (Informax) and bioinformatics programs available online.

X. dendrorhoustransformation

X. dendrorhous transformation was performed by electroporation according to [40] and [41]. Electrocompetent cells were prepared from an exponential culture with DO600nm = 1.2, cultured in YM medium and electroporated using a BioRad Gene Pulser Xcell with PC and CE modules under the following conditions: 125 mF, 600 Ω, 0.45 kV. The yeast were transformed with 4 μl of a mixture of purified DNA fragments (1 μg of each fragment) that were amplified by PCR with Pfu DNA pol and primers with 5′ complementary ends to allow their assembly by homologous recombination. In each transformation event, in addition to the selection marker and/or the crtS gene expression cassette, “up” and “down” DNA fragments were included targeting the insertion into the integration site. The hygromycin B resistance and crtS gene expression cassettes were amplified from plasmids pMN-Hyg and pBS-PTEF-crtS-Tact, respectively, and the “up” and “down” DNA fragments were amplified from X. dendrorhous wild-type genomic DNA. Transformant selection was performed on YM 1.5% agar plates supplemented with 15 μg/ml hygromycin B. As strain UCD 67–385 is diploid [31], heterozygous transformants were obtained. To obtain homozygous transformants, the double recombinant method (DRM) [30] was applied. The transformant strains were confirmed as X. dendrorhous by examining the ITS1, 5.8 rRNA gene and ITS2 DNA sequences [42, 43].

RNA extraction, single strand DNA synthesis and RT-qPCR

To measure the relative crtS gene expression, total RNA was extracted from 50 h yeast cultures (late exponential phase of growth) grown at 22°C with constant agitation in YM medium. The cell pellets from 5 ml culture aliquots were frozen with liquid nitrogen and stored at -80°C until use. Total RNA extraction from the cell pellets was performed by mechanical rupture with 0.5 mm glass beads (BioSpec) during 10 min of vortexing, followed by the addition of Tri-Reagent (Ambion). The lysate was incubated for 5 min at room temperature and 200 μl of chloroform per ml of Tri-Reagent used was added, mixed, and centrifuged for 5 min at 4,000 × g. Following this centrifugation, the aqueous phase was recovered. The RNA was precipitated by adding two volumes of isopropanol and incubating at room temperature for 10 min. The RNA was washed with 75% ethanol, suspended in RNase-free H2O and quantified by absorbance determination at 260 nm in a double beam Shimadzu UV-150-20 spectrophotometer.

The synthesis of cDNA was performed according to the M-MLV reverse transcriptase (Invitrogen) manufacturer’s protocol with 5 μg of total RNA in a final volume of 11 μl. The determination of the relative crtS gene expression levels was performed in an Mx3000P quantitative PCR system (Stratagene) using 1 μl of the reverse transcription reaction, 0.25 μM of each primer (Additional file 1: Table S1) and 10 μl of the SensiMix SYBR Green I (Quantace) kit reagent in a final volume of 20 μl. The obtained Ct values were normalized to the respective value of the actin gene [GenBank: X89898.1] [44] and expressed using the 2-ΔCT method [45, 46].

Carotenoid extraction and RP-HPLC

Carotenoids were extracted from cell pellets from 24, 50 and 96-hours-old yeast cultures (early exponential, late exponential and late stationary phase of growth, respectively) grown at 22°C with constant agitation in YM medium using the acetone extraction method [12]. Total carotenoids were quantified by absorbance at 465 nm using an absorption coefficient of A1% = 2,100. The analyses were performed at least in triplicate, and pigments were normalized relative to the dry weight of the yeast. Carotenoids were separated by RP-HPLC using a reverse phase RP-18 LiChroCART 125–4 (Merck) column with acetonitrile:methanol:isopropanol (85:10:5 v/v) as the mobile phase under isocratic conditions with a 1 ml/min flux. The elusion spectra were recovered using a diode array detector, and carotenoids were identified by their spectra and retention time according to standards.

Declarations

Acknowledgements

This work was supported by projects: Fondecyt 11121200 to JA and Fondecyt 1100324 to VC.

Authors’ Affiliations

(1)
Departamento de Ciencias Ecológicas, Facultad de Ciencias, Universidad de Chile, Las Palmeras 3425, Casilla, Santiago, 653, Chile
(2)
Departamento de Química, Facultad de Ciencias, Universidad de Chile, Las Palmeras 3425, Casilla, Santiago, 653, Chile

References

  1. Britton G, Pfander H: Liaaen-Jensen S. 1998, Handbook. Birkhäuser Verlag: CarotenoidGoogle Scholar
  2. Schroeder WA, Johnson EA: Carotenoids protect Phaffia rhodozyma against singlet oxygen damage. J Indust Microbiol. 1995, 14: 502-507. 10.1007/BF01573965.View ArticleGoogle Scholar
  3. Miki W: Biological functions and activities of animal carotenoids. Pure Appl Chem. 1991, 63: 141-146. 10.1351/pac199163010141.View ArticleGoogle Scholar
  4. Higuera-Ciapara I, Felix-Valenzuela L, Goycoolea FM: Astaxanthin: a review of its chemistry and applications. Crit Rev Food Sci Nutr. 2006, 46: 185-196. 10.1080/10408690590957188.View ArticleGoogle Scholar
  5. Hu Z-C, Zheng Y-G, Wang Z, Shen Y-C: Effect of sugar-feeding strategies on astaxanthin production by Xanthophyllomyces dendrorhous. World J Microb Biot. 2005, 21: 771-775. 10.1007/s11274-004-5566-x.View ArticleGoogle Scholar
  6. Yamane Y, Higashida K, Nakashimada Y, Kakizono T, Nishio N: Influence of oxygen and glucose on primary metabolism and astaxanthin production by Phaffia rhodozyma in batch and fed-batch cultures: kinetic and stoichiometric analysis. Appl Environ Microbiol. 1997, 63: 4471-4478.Google Scholar
  7. Liu YS, Wu JY: Use of n-hexadecane as an oxygen vector to improve Phaffia rhodozyma growth and carotenoid production in shake-flask cultures. J Appl Microbiol. 2006, 101: 1033-1038. 10.1111/j.1365-2672.2006.03009.x.View ArticleGoogle Scholar
  8. Johnson EA, Lewis MJ: Astaxanthin formation by the yeast Phaffia rhodozyma. J Gen Microbiol. 1979, 115: 173-183. 10.1099/00221287-115-1-173.View ArticleGoogle Scholar
  9. Hu Z-C, Zheng Y-G, Wang Z, Shen Y-C: pH control strategy in astaxanthin fermentation bioprocess by Xanthophyllomyces dendrorhous. Enzyme Microb Technol. 2006, 39: 586-590. 10.1016/j.enzmictec.2005.11.017.View ArticleGoogle Scholar
  10. Flores-Cotera L, Martin R, Sanchez S: Citrate, a possible precursor of astaxanthin in Phaffia rhodozyma: influence of varying levels of ammonium, phosphate and citrate in a chemically defined medium. Appl Microbiol Biotechnol. 2001, 55: 341-347. 10.1007/s002530000498.View ArticleGoogle Scholar
  11. An G-H, Johnson EA: Influence of light on growth and pigmentation of the yeast Phaffia rhodozyma. Antonie Van Leeuwenhoek. 1990, 57: 191-203. 10.1007/BF00400151.View ArticleGoogle Scholar
  12. An G-H, Schuman DB, Johnson EA: Isolation of Phaffia rhodozyma mutants with increased astaxanthin content. Appl Environ Microbiol. 1989, 55: 116-124.Google Scholar
  13. Lewis MJ, Ragot N, Berlant MC, Miranda M: Selection of astaxanthin-overproducing mutants of Phaffia rhodozyma with β-ionone. Appl Environ Microbiol. 1990, 56: 2944-2945.Google Scholar
  14. Retamales P, León R, Martinez C, Hermosilla G, Pincheira G, Cifuentes V: Complementation analysis with new genetic markers in Phaffia rhodozyma. Antonie Van Leeuwenhoek. 1998, 73: 229-236. 10.1023/A:1000828220033.View ArticleGoogle Scholar
  15. Ukibe K, Katsuragi T, Tani Y, Takagi H: Efficient screening for astaxanthin-overproducing mutants of the yeast Xanthophyllomyces dendrorhous by flow cytometry. FEMS Microbiol Lett. 2008, 286: 241-248. 10.1111/j.1574-6968.2008.01278.x.View ArticleGoogle Scholar
  16. Schmidt I, Schewe H, Gassel S, Jin C, Buckingham J, Hümbelin M, Sandmann G, Schrader J: Biotechnological production of astaxanthin with Phaffia rhodozyma/Xanthophyllomyces dendrorhous. Appl Microbiol Biotechnol. 2011, 89: 555-571. 10.1007/s00253-010-2976-6.View ArticleGoogle Scholar
  17. Verdoes JC, Sandmann G, Visser H, Diaz M, van Mossel M, van Ooyen AJJ: Metabolic engineering of the carotenoid biosynthetic pathway in the yeast Xanthophyllomyces dendrorhous (Phaffia rhodozyma). Appl Environ Microbiol. 2003, 69: 3728-3738. 10.1128/AEM.69.7.3728-3738.2003.View ArticleGoogle Scholar
  18. Visser H, Sandmann G, Verdoes JC: Xanthophylls in Fungi. Microbial Processes and Products. Volume 18. Edited by: Barredo JL. 2005, New York: Humana Press, 257-272.View ArticleGoogle Scholar
  19. Breitenbach J, Visser H, Verdoes JC, van Ooyen AJJ, Sandmann G: Engineering of geranylgeranyl pyrophosphate synthase levels and physiological conditions for enhanced carotenoid and astaxanthin synthesis in Xanthophyllomyces dendrorhous. Biotechnol Lett. 2011, 33: 755-761. 10.1007/s10529-010-0495-2.View ArticleGoogle Scholar
  20. Gassel S, Schewe H, Schmidt I, Schrader J, Sandmann G: Multiple improvement of astaxanthin biosynthesis in Xanthophyllomyces dendrorhous by a combination of conventional mutagenesis and metabolic pathway engineering. Biotechnol Lett. 2013, 35: 565-569. 10.1007/s10529-012-1103-4.View ArticleGoogle Scholar
  21. Andrewes AG, Phaff HJ, Starr MP: Carotenoids of Phaffia rhodozyma, a red-pigmented fermenting yeast. Phytochemistry. 1976, 15: 1003-1007. 10.1016/S0031-9422(00)84390-3.View ArticleGoogle Scholar
  22. An G-H, Cho M-H, Johnson EA: Monocyclic carotenoid biosynthetic pathway in the yeast Phaffia rhodozyma (Xanthophyllomyces dendrorhous). J Biosci Bioeng. 1999, 88: 189-193. 10.1016/S1389-1723(99)80200-X.View ArticleGoogle Scholar
  23. Shao Z, Zhao H, Zhao H: DNA assembler, an in vivo genetic method for rapid construction of biochemical pathways. Nucleic Acids Res. 2009, 37: e16-10.1093/nar/gkn724.View ArticleGoogle Scholar
  24. Wery J, Gutker D, Renniers ACHM, Verdoes JC, van Ooyen AJJ: High copy number integration into the ribosomal DNA of the yeast Phaffia rhodozyma. Gene. 1997, 184: 89-97. 10.1016/S0378-1119(96)00579-3.View ArticleGoogle Scholar
  25. Alcaíno J, Barahona S, Carmona M, Lozano C, Marcoleta A, Niklitschek M, Sepúlveda D, Baeza M, Cifuentes V: Cloning of the cytochrome p450 reductase (crtR) gene and its involvement in the astaxanthin biosynthesis of Xanthophyllomyces dendrorhous. BMC Microbiol. 2008, 8: 169-10.1186/1471-2180-8-169.View ArticleGoogle Scholar
  26. Niklitschek M, Alcaíno J, Barahona S, Sepúlveda D, Lozano C, Carmona M, Marcoleta A, Martínez C, Lodato P, Baeza M: Genomic organization of the structural genes controlling the astaxanthin biosynthesis pathway of Xanthophyllomyces dendrorhous. Biol Res. 2008, 41: 93-108.View ArticleGoogle Scholar
  27. Loto I, Gutiérrez MS, Barahona S, Sepúlveda D, Martínez-Moya P, Baeza M, Cifuentes V, Alcaíno J: Enhancement of carotenoid production by disrupting the C22-sterol desaturase gene (CYP61) in Xanthophyllomyces dendrorhous. BMC Microbiol. 2012, 12: 235-10.1186/1471-2180-12-235.View ArticleGoogle Scholar
  28. Álvarez V, Rodríguez-Sáiz M, de la Fuente JL, Gudiña EJ, Godio RP, Martín JF, Barredo JL: The crtS gene of Xanthophyllomyces dendrorhous encodes a novel cytochrome-P450 hydroxylase involved in the conversion of β-carotene into astaxanthin and other xanthophylls. Fungal Genet Biol. 2006, 43: 261-272. 10.1016/j.fgb.2005.12.004.View ArticleGoogle Scholar
  29. Ojima K, Breitenbach J, Visser H, Setoguchi Y, Tabata K, Hoshino T, van den Berg J, Sandmann G: Cloning of the astaxanthin synthase gene from Xanthophyllomyces dendrorhous (Phaffia rhodozyma) and its assignment as a β-carotene 3-hydroxylase/4-ketolase. Mol Genet Genomics. 2006, 275: 148-158. 10.1007/s00438-005-0072-x.View ArticleGoogle Scholar
  30. Niklitschek M, Baeza M, Fernández-Lobato M, Cifuentes V: Generation of Astaxanthin Mutants in Xanthophyllomyces dendrorhous Using a Double Recombination Method Based on Hygromycin Resistance. Microbial Carotenoids From Fungi, Volume 898. Edited by: Barredo JL. 2012, New York: Humana Press, 219-234.View ArticleGoogle Scholar
  31. Hermosilla G, Martínez C, Retamales P, León R, Cifuentes V: Genetic determination of ploidy level in Xanthophyllomyces dendrorhous. Antonie Van Leeuwenhoek. 2003, 84: 279-287. 10.1023/A:1026090008405.View ArticleGoogle Scholar
  32. Lodato P, Alcaíno J, Barahona S, Niklitschek M, Carmona M, Wozniak A, Baeza M, Jiménez A, Cifuentes V: Expression of the carotenoid biosynthesis genes in Xanthophyllomyces dendrorhous. Biol Res. 2007, 40: 73-View ArticleGoogle Scholar
  33. Wozniak A, Lozano C, Barahona S, Niklitschek M, Marcoleta A, Alcaíno J, Sepulveda D, Baeza M, Cifuentes V: Differential carotenoid production and gene expression in Xanthophyllomyces dendrorhous grown in a nonfermentable carbon source. FEMS Yeast Res. 2011, 11: 252-262. 10.1111/j.1567-1364.2010.00711.x.View ArticleGoogle Scholar
  34. Radonić A, Thulke S, Mackay IM, Landt O, Siegert W, Nitsche A: Guideline to reference gene selection for quantitative real-time PCR. Biochem Biophys Res Commun. 2004, 313: 856-862. 10.1016/j.bbrc.2003.11.177.View ArticleGoogle Scholar
  35. Miziorko HM: Enzymes of the mevalonate pathway of isoprenoid biosynthesis. Arch Biochem Biophys. 2011, 505: 131-143. 10.1016/j.abb.2010.09.028.View ArticleGoogle Scholar
  36. Retamales P, Hermosilla G, Leon R, Martı́nez C, Jimenez A, Cifuentes V: Development of the sexual reproductive cycle of Xanthophyllomyces dendrorhous. J Microbiol Meth. 2002, 48: 87-93. 10.1016/S0167-7012(01)00349-9.View ArticleGoogle Scholar
  37. Sambrook J, Russell DW: Molecular cloning: a laboratory manual. 2001, Cold Spring Harbour, New York: Cold Spring Harbour Laboratory Press, Volume 1–3Google Scholar
  38. Boyle JS, Lew AM: An inexpensive alternative to glassmilk for DNA purification. Trends Genet. 1995, 11: 8-10.1016/S0168-9525(00)88977-5.View ArticleGoogle Scholar
  39. Horton RM, Hunt HD, Ho SN, Pullen JK, Pease LR: Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene. 1989, 77: 61-68. 10.1016/0378-1119(89)90359-4.View ArticleGoogle Scholar
  40. Adrio JL, Veiga M: Transformation of the astaxanthin-producing yeast Phaffia rhodozyma. Biotechnol Tech. 1995, 9: 509-512. 10.1007/BF00159567.View ArticleGoogle Scholar
  41. Kim IG, Nam SK, Sohn JH, Rhee SK, An GH, Lee SH, Choi ES: Cloning of the ribosomal protein L41 gene of Phaffia rhodozyma and its use as a drug resistance marker for transformation. Appl Environ Microbiol. 1998, 64: 1947-1949.Google Scholar
  42. Fell JW, Blatt GM: Separation of strains of the yeasts Xanthophyllomyces dendrorhous and Phaffia rhodozyma based on rDNA IGS and ITS sequence analysis. J Ind Microbiol Biotechnol. 1999, 23: 677-681. 10.1038/sj.jim.2900681.View ArticleGoogle Scholar
  43. Reyes E, Barahona S, Fischman O, Niklitschek M, Baeza M, Cifuentes V: Genetic polymorphism of clinical and environmental strains of Pichia anomala. Biol Res. 2004, 37: 747-757.View ArticleGoogle Scholar
  44. Wery J, Dalderup MJM, Ter Linde J, Boekhout T, Van Ooyen AJJ: Structural and phylogenetic analysis of the actin gene from the yeast Phaffia rhodozyma. Yeast. 1996, 12: 641-651. 10.1002/(SICI)1097-0061(19960615)12:7<641::AID-YEA952>3.0.CO;2-2.View ArticleGoogle Scholar
  45. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001, 25: 402-408. 10.1006/meth.2001.1262.View ArticleGoogle Scholar
  46. Schmittgen TD, Livak KJ: Analyzing real-time PCR data by the comparative CT method. Nat Protoc. 2008, 3: 1101-1108. 10.1038/nprot.2008.73.View ArticleGoogle Scholar

Copyright

Advertisement